- Home
- FOLD vs LAUR Comparison
FOLD vs LAUR Comparison
Compare FOLD & LAUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- LAUR
- Stock Information
- Founded
- FOLD 2002
- LAUR 1989
- Country
- FOLD United States
- LAUR United States
- Employees
- FOLD N/A
- LAUR N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- LAUR Other Consumer Services
- Sector
- FOLD Health Care
- LAUR Real Estate
- Exchange
- FOLD Nasdaq
- LAUR Nasdaq
- Market Cap
- FOLD 2.9B
- LAUR 3.3B
- IPO Year
- FOLD 2007
- LAUR 2017
- Fundamental
- Price
- FOLD $6.16
- LAUR $22.74
- Analyst Decision
- FOLD Buy
- LAUR Buy
- Analyst Count
- FOLD 10
- LAUR 2
- Target Price
- FOLD $16.22
- LAUR $20.50
- AVG Volume (30 Days)
- FOLD 5.0M
- LAUR 696.4K
- Earning Date
- FOLD 05-01-2025
- LAUR 07-31-2025
- Dividend Yield
- FOLD N/A
- LAUR N/A
- EPS Growth
- FOLD N/A
- LAUR 143.51
- EPS
- FOLD N/A
- LAUR 1.90
- Revenue
- FOLD $543,141,000.00
- LAUR $1,527,432,000.00
- Revenue This Year
- FOLD $19.85
- LAUR $2.58
- Revenue Next Year
- FOLD $23.50
- LAUR $7.78
- P/E Ratio
- FOLD N/A
- LAUR $11.93
- Revenue Growth
- FOLD 28.25
- LAUR 1.26
- 52 Week Low
- FOLD $5.81
- LAUR $13.60
- 52 Week High
- FOLD $12.65
- LAUR $23.61
- Technical
- Relative Strength Index (RSI)
- FOLD 41.91
- LAUR 63.62
- Support Level
- FOLD $6.03
- LAUR $21.39
- Resistance Level
- FOLD $6.37
- LAUR $23.61
- Average True Range (ATR)
- FOLD 0.24
- LAUR 0.44
- MACD
- FOLD 0.04
- LAUR -0.08
- Stochastic Oscillator
- FOLD 41.67
- LAUR 79.88
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About LAUR Laureate Education Inc.
Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its geographical segments include Peru and Mexico.